Alzheimer’s disease risk reduction in clinical practice: a priority in the emerging field of preventive neurology

This publication has 250 references indexed in Scilit:

• The projected effect of risk factor reduction on Alzheimer's disease prevalence
  The Lancet Neurology, 2011
• Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans
  Proceedings of the National Academy of Sciences, 2011
• Vulnerability to Stress, Anxiety, and Development of Dementia in Old Age
  The American Journal of Geriatric Psychiatry, 2011
• Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms
  Journal of Biological Chemistry, 2011
• Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN)
  Psychological Medicine, 2011
• Association of Muscle Strength With the Risk of Alzheimer Disease and the Rate of Cognitive Decline in Community-Dwelling Older Persons
  Archives of Neurology, 2009
• Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA?
  Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009
• Increased visceral fat and decreased energy expenditure during the menopausal transition
  International Journal of Obesity, 2008
• The Effects of Prolonged Stress and APOE Genotype on Memory and Cortisol in Older Adults
  Biological Psychiatry, 2007
• ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study
  Archives of Neurology, 2006